You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The portable, battery-operated system will be an interim solution for decentralized testing in places where power may be unreliable.
The 20-gene assay, which BioMérieux will develop on the BioFire FilmArray platform, distinguishes active TB from latent TB, viral, and bacterial infections.
At ASM Microbe, the University of Wisconsin's Caitlin Pepperell described her work putting Mycobacterium tuberculosis genomics into a historical context.
Using a protocol developed at the University of Oxford, the researchers hope that nanopore sequencing can aid diagnosis and drug resistance profiling in remote areas.
Jean-Laurent Casanova aims to identify single-gene mutations that compromise the immunity of normally healthy individuals and lead to severe infectious disease.
The medium has been cleared for transporting samples potentially containing flu A and tuberculosis.
The exclusive two-way licensing deal also allows Akonni to commercialize Righton's molecular diagnostic tests outside of China.
In PLOS this week: small bowel adenocarcinoma mutation signatures, omic analysis of M. tuberculosis strains, and more.
The new funding will be used to develop a sample preparation module to concentrate bacteria and increase test sensitivity.
In Nature this week: genomes of two organisms that regenerate body parts, sea lamprey genome, and more.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.